MRF-Logo2019-Horizontal-RGB
srcarcaterra
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

srcarcaterra

Forum Replies Created

Viewing 1 reply thread
  • Replies
      • July 9, 2018 at 12:59 pm
      srcarcaterra
      Participant

        Juan,   Were you able to figure out your dosing so that you could ride again?  I, too, am a cyclist.  I had 4 cycles of Opdivo/Yervoy in 2016.  I develeoped adrenal insufficiency and was put on 7.5 mg of prednisone.  I find when I ride, I have no power in my legs, get cramps in my quads, get dizzy and confused on long hard rides.  I also have little appetite, chills, joint pain and it takes days for me to recover enough to ride again.  I am happy to be alive, but miss being able to do long hard rides.  Have  you figured anything out?  Nice to find a fellow cyclist with this condition.   

        Thanks,

        Steve

    Viewing 1 reply thread
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics